Digestives & Intestinal Remedies - CIS

  • CIS
  • In 2024, the Digestives & Intestinal Remedies market market in CIS generated a revenue of US$0.38bn.
  • It is projected to experience an annual growth rate of 3.90% (CAGR 2024-2029).
  • Among all countries, in China leads the market, generating a revenue of US$4,408.00m in 2024.
  • When considering the population, the per person revenue in CIS amounts to US$1.57 in 2024.
  • In the CIS market, there is a growing trend towards natural and herbal digestive remedies due to a cultural preference for traditional remedies.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in CIS is experiencing steady growth, driven by customer preferences for natural and herbal remedies, increasing awareness about digestive health, and favorable macroeconomic factors.

Customer preferences:
Customers in CIS countries are increasingly opting for natural and herbal remedies for digestive issues. This preference is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for digestive remedies that are made from natural ingredients and do not contain artificial additives or preservatives.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in CIS is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and promote better digestion. Probiotic supplements and foods such as yogurt and kefir are becoming more widely available in CIS countries, as consumers recognize their positive impact on digestive health.Another trend in the market is the growing demand for over-the-counter (OTC) digestive remedies. OTC products are easily accessible and do not require a prescription, making them convenient for consumers. The availability of a wide range of OTC digestive remedies, such as antacids, laxatives, and anti-diarrheal medications, is driving the growth of the market in CIS countries.

Local special circumstances:
CIS countries have a diverse population with varying dietary habits and lifestyles. This diversity creates a demand for a wide range of digestive remedies to address different digestive issues. For example, some individuals may require remedies for acid reflux, while others may need products to alleviate constipation. Manufacturers and suppliers in the market need to cater to these diverse needs to effectively serve the CIS market.

Underlying macroeconomic factors:
The Digestives & Intestinal Remedies market in CIS is also influenced by macroeconomic factors such as population growth, increasing disposable incomes, and improving healthcare infrastructure. As the population in CIS countries continues to grow, the demand for healthcare products, including digestive remedies, is expected to increase. Rising disposable incomes allow consumers to afford these products, while improving healthcare infrastructure ensures better access to healthcare services and products.In conclusion, the Digestives & Intestinal Remedies market in CIS is developing due to customer preferences for natural and herbal remedies, the increasing popularity of probiotics, the demand for OTC products, local special circumstances, and favorable macroeconomic factors. Manufacturers and suppliers in the market need to understand these trends and factors to effectively meet the needs of the CIS market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)